World Solve

Future workers may combine employment, freelancing, caregiving, entrepreneurship, and AI-assisted production. Benefits must follow people across contracts without making innovation or small-business hiring impossible. The solution must work with limited capital, intermittent services, and local maintenance capacity. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.

Future crops, microbes, and fermentation systems may depend on patented seeds, strains, software, or inputs. The open problem is preserving farmer and national autonomy while rewarding useful innovation. The solution must work with limited capital, intermittent services, and local maintenance capacity. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.

Distributed biotech facilities may bring innovation closer to communities while introducing new biosafety and waste-management requirements. Cities need transparent zoning, monitoring, emergency planning, and public participation. The solution must work with limited capital, intermittent services, and local maintenance capacity. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.

When corporations patent forms of rainwater collection or composition in water-scarce areas, ordinary puddles and runoff become potential infringement sites. The challenge is designing water-rights frameworks that protect both innovation incentives and the basic human need for free access to precipitation.

Synthetic biology and AI-assisted design may create biological capabilities that are both socially valuable and potentially dangerous. The unresolved problem is building oversight that reduces misuse risk while keeping legitimate research open and productive. The challenge is especially acute in informal settlements, where legacy systems, coordination failures, and weak oversight can magnify harm.

Europe must support Ukraine while rebuilding its own defence posture and replacing Russian energy imports, all under fiscal and political constraints. Defence-industrial coordination platforms and grid-optimization tools are key areas for innovation.

Europe produces strong scientific research but struggles to grow globally dominant tech firms due to fragmented markets and risk-averse capital. Cross-border venture networks and translational research platforms can bridge the gap.

Remote and poor communities remain off-grid. Decentralized renewables and finance innovations can expand access.

Most nations invest little in research, limiting innovation. Regional funding mechanisms and collaboration can boost capacity.

Complex registration and licensing processes deter innovation. One-stop digital portals can reduce friction.

Underrepresented groups face barriers in tech and science. Inclusive incubators and funding programs can address this.

Research outputs rarely translate into commercial products due to weak collaboration structures. Joint R&D centers and innovation clusters could bridge this gap.

Researchers and entrepreneurs struggle to obtain reliable datasets for building solutions. Open-data portals with standardized formats and APIs could catalyze innovation.

Weak enforcement means inventors and creators often see their work copied without compensation, discouraging R&D investment. Streamlined regional patent systems could better protect innovators.

These diseases receive little research funding despite affecting hundreds of millions, because they mainly impact low-income populations. Cheap diagnostics and mass drug administration logistics need innovation.

Low-income urban districts across seismic fault lines consist of unreinforced concrete block buildings highly susceptible to collapse during major earthquakes.

Malnutrition rates spike dramatically in areas affected by war, but delivering treatment consistently in unstable, hard-to-reach regions remains a persistent logistical and medical challenge. Solving this requires both medical and access innovation.

New, fast-growing markets often attract inexperienced investors right before major price crashes, leading to significant personal financial losses. Protecting newer investors without stifling innovation remains an unresolved balance.

Competition can drive genuine excellence and innovation, but it also guarantees that some participants will predictably fail through no unique fault of their own. This unresolved tension underlies debates about fairness in education, employment, and markets.

New industries, especially in tech, often end up dominated by one or two giant companies before regulation catches up. This can shut out competition and innovation before it even has a chance to grow.